Ligand Pharmaceuticals
LGND
#2746
Rank
NZ$11.15 B
Marketcap
NZ$556.57
Share price
0.65%
Change (1 day)
198.28%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$0.94 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.94 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.93 B375.31%
2024-12-31NZ$0.19 B44.66%
2023-12-31NZ$0.13 B-47.55%
2022-12-31NZ$0.26 B-62.7%
2021-12-31NZ$0.69 B-22.9%
2020-12-31NZ$0.90 B-16.27%
2019-12-31NZ$1.08 B3.55%
2018-12-31NZ$1.04 B193.62%
2017-12-31NZ$0.35 B6.68%
2016-12-31NZ$0.33 B0.81%
2015-12-31NZ$0.33 B10.82%
2014-12-31NZ$0.29 B344.69%
2013-12-31NZ$67.05 M-29.08%
2012-12-31NZ$94.54 M-34.35%
2011-12-31NZ$0.14 B38.18%
2010-12-31NZ$0.10 B-45.17%
2009-12-31NZ$0.19 B-39.33%
2008-12-31NZ$0.31 B66.47%
2007-12-31NZ$0.18 B-55.61%
2006-12-31NZ$0.42 B-31.82%
2005-12-31NZ$0.62 B8.81%
2004-12-31NZ$0.57 B5.66%
2003-12-31NZ$0.54 B40.54%
2002-12-31NZ$0.38 B-8.86%
2001-12-31NZ$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$210.78 B 22,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$206.39 B 21,818.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$150.33 B 15,864.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$146.69 B 15,479.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$24.35 B 2,486.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$145.71 B 15,374.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$116.87 B 12,311.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$105.97 B 11,154.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$0.14 B-84.88%๐Ÿ‡บ๐Ÿ‡ธ USA